For citations:
Isaev P.A., Rumyantsev P.O., Polkin V.V., Ilyin A.A., Syomin D.Yu., Agababyan T.A., Vasilkov S.V., Medvedev V.S. CLINICAL EXPERIENCE OF NEXAVAR (SORAFENIB) APPLICATION IN PATIENTS WITH METASTATIC DIFFERENTIATED THYROID CANCER RESISTANT TO THERAPY 131I. Head and Neck Tumors (HNT). 2014;(2):46-50. (In Russ.) https://doi.org/10.17650/2222-1468-2014-0-2-46-50
Email this article 